• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 Clinical Trials: Unraveling a Methodological Gordian Knot.

作者信息

Mathioudakis Alexander G, Fally Markus, Hashad Rola, Knight Sean, Felton Timothy, Vestbo Jørgen

机构信息

Manchester University NHS Foundation Trust Manchester Academic Health Science Centre Manchester, United Kingdom.

Division of Infection, Immunity and Respiratory Medicine The University of Manchester Manchester, United Kingdom.

出版信息

Am J Respir Crit Care Med. 2020 Sep 1;202(5):635-637. doi: 10.1164/rccm.202005-1942ED.

DOI:10.1164/rccm.202005-1942ED
PMID:32634026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7462407/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c84/7462407/8188250f84d9/rccm.202005-1942EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c84/7462407/8188250f84d9/rccm.202005-1942EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c84/7462407/8188250f84d9/rccm.202005-1942EDf1.jpg

相似文献

1
COVID-19 Clinical Trials: Unraveling a Methodological Gordian Knot.COVID-19临床试验：解开方法学上的死结。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):635-637. doi: 10.1164/rccm.202005-1942ED.
2
Editorial: Clinical trial design in the era of COVID-19.社论：新冠疫情时代的临床试验设计
Clin Trials. 2020 Oct;17(5):465-466. doi: 10.1177/1740774520940230. Epub 2020 Jul 10.
3
COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance.COVID-19 临床试验：改善我们的研究基础设施和相关性的教学时刻。
Ann Intern Med. 2020 Oct 20;173(8):652-653. doi: 10.7326/M20-2959. Epub 2020 Jun 16.
4
COVID-19 and hydroxychloroquine: Is the wonder drug failing?新冠病毒与羟氯喹：神药失效了吗？
Eur J Intern Med. 2020 Aug;78:1-3. doi: 10.1016/j.ejim.2020.06.002. Epub 2020 Jun 4.
5
Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy.促进更好的临床试验和药物信息作为意大利 COVID-19 紧急情况的公共卫生干预措施。
Ann Intern Med. 2020 Oct 20;173(8):654-655. doi: 10.7326/M20-3775. Epub 2020 Jun 16.
6
[Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].在此次新冠疫情期间短期使用羟氯喹治疗的情况下，是否需要进行眼科监测？
J Fr Ophtalmol. 2020 Jun;43(6):548-549. doi: 10.1016/j.jfo.2020.04.014. Epub 2020 Apr 30.
7
COVID-19 Presenting as Acute Hepatitis.以急性肝炎形式出现的新型冠状病毒肺炎
Am J Gastroenterol. 2020 Jun;115(6):941-942. doi: 10.14309/ajg.0000000000000660.
8
SARS-CoV-2 pandemic and the need for transplant-oriented trials.严重急性呼吸综合征冠状病毒2型大流行与开展以移植为导向的试验的必要性。
Transpl Int. 2020 Aug;33(8):966-968. doi: 10.1111/tri.13626. Epub 2020 May 14.
9
How diabetes management is adapting amid the COVID-19 pandemic.在新冠疫情期间糖尿病管理是如何进行调整的。
Lancet Diabetes Endocrinol. 2020 Jul;8(7):571. doi: 10.1016/S2213-8587(20)30181-9. Epub 2020 May 15.
10
Treading Lightly in a Pandemic: #Zentensivist Reflections on COVID-19.疫情期间的轻履前行：#禅修者对新冠疫情的思考
Chest. 2020 Aug;158(2):471-473. doi: 10.1016/j.chest.2020.04.013. Epub 2020 Apr 21.

引用本文的文献

1
Clinical trials in Bosnia and Herzegovina: Challenges and future perspectives.波斯尼亚和黑塞哥维那的临床试验：挑战与未来展望。
Contemp Clin Trials Commun. 2022 Jun 28;28:100953. doi: 10.1016/j.conctc.2022.100953. eCollection 2022 Aug.
2
Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study.在慢性阻塞性肺疾病急性加重期随机临床试验中评估治疗成败作为一项结局指标。一项Meta流行病学研究。
Biomedicines. 2021 Dec 5;9(12):1837. doi: 10.3390/biomedicines9121837.
3
Biological and Clinical Significance of Adaptive Evolution of Coronaviruses.

本文引用的文献

1
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019（COVID-19）患者中的应用：来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
2
Race to find COVID-19 treatments accelerates.寻找新冠病毒治疗方法的竞赛加速。
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
3
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
冠状病毒适应性进化的生物学及临床意义
Life (Basel). 2021 Oct 23;11(11):1129. doi: 10.3390/life11111129.
4
Chronic obstructive pulmonary disease and COVID-19: interrelationships.慢性阻塞性肺疾病与 COVID-19：相互关系。
Curr Opin Pulm Med. 2022 Mar 1;28(2):76-83. doi: 10.1097/MCP.0000000000000834.
5
Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19.使用 LungPass 平台进行自动肺部声音分析：一种用于识别 COVID-19 下呼吸道受累的敏感且特异的工具。
Eur Respir J. 2021 Dec 2;58(6). doi: 10.1183/13993003.01907-2021. Print 2021 Dec.
6
Length of remdesivir treatment in patients with severe COVID-19.重症新型冠状病毒肺炎患者使用瑞德西韦的治疗时长。
Breathe (Sheff). 2021 Mar;17(1):200276. doi: 10.1183/20734735.0276-2020.
7
Guideline-directed management of COVID-19: Do's and Don'ts.COVID-19 指南导向管理：注意事项。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00753-2021. Print 2021 Apr.
8
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.成人 2019 冠状病毒病（COVID-19）住院患者管理：欧洲呼吸学会临床实践指南。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00048-2021. Print 2021 Apr.
9
Rationale for azithromycin in COVID-19: an overview of existing evidence.COVID-19 中使用阿奇霉素的理由：现有证据概述。
BMJ Open Respir Res. 2021 Jan;8(1). doi: 10.1136/bmjresp-2020-000806.
10
Pandemic trials: evidence-based medicine on steroids.大流行试验：打了类固醇的循证医学。
Eur Respir J. 2020 Dec 24;56(6). doi: 10.1183/13993003.04116-2020. Print 2020 Dec.
神经氨酸酶抑制剂在降低甲型 H1N1pdm09 流感病毒感染住院患者死亡率中的效果：一项个体参与者数据的荟萃分析。
Lancet Respir Med. 2014 May;2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4. Epub 2014 Mar 19.